DE602007009717D1 - Verfahren zur strahlensensibilisierung von tumoren mit einem strahlensensibilisierungsmittel - Google Patents

Verfahren zur strahlensensibilisierung von tumoren mit einem strahlensensibilisierungsmittel

Info

Publication number
DE602007009717D1
DE602007009717D1 DE602007009717T DE602007009717T DE602007009717D1 DE 602007009717 D1 DE602007009717 D1 DE 602007009717D1 DE 602007009717 T DE602007009717 T DE 602007009717T DE 602007009717 T DE602007009717 T DE 602007009717T DE 602007009717 D1 DE602007009717 D1 DE 602007009717D1
Authority
DE
Germany
Prior art keywords
sensitivization
tumors
radiating
sensitizing agent
radiation sensitizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007009717T
Other languages
English (en)
Inventor
James L Diebold
Robert L Hudkins
Sheila J Miknyoczki
Bruce Ruggeri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon LLC
Original Assignee
Cephalon LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39259576&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602007009717(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cephalon LLC filed Critical Cephalon LLC
Publication of DE602007009717D1 publication Critical patent/DE602007009717D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DE602007009717T 2006-11-20 2007-11-20 Verfahren zur strahlensensibilisierung von tumoren mit einem strahlensensibilisierungsmittel Active DE602007009717D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86003606P 2006-11-20 2006-11-20
PCT/US2007/024271 WO2008063644A1 (en) 2006-11-20 2007-11-20 Method of radio-sensitizing tumors using a radio-sensitizing agent

Publications (1)

Publication Number Publication Date
DE602007009717D1 true DE602007009717D1 (de) 2010-11-18

Family

ID=39259576

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007009717T Active DE602007009717D1 (de) 2006-11-20 2007-11-20 Verfahren zur strahlensensibilisierung von tumoren mit einem strahlensensibilisierungsmittel

Country Status (18)

Country Link
US (1) US20080146556A1 (de)
EP (1) EP2086525B1 (de)
JP (1) JP5542444B2 (de)
CN (1) CN101784268B (de)
AR (1) AR063869A1 (de)
AT (1) ATE483456T1 (de)
AU (1) AU2007321987B2 (de)
CA (1) CA2671517C (de)
CL (1) CL2007003331A1 (de)
DE (1) DE602007009717D1 (de)
ES (1) ES2352817T3 (de)
HK (1) HK1137347A1 (de)
IL (1) IL198519A (de)
MX (1) MX2009005292A (de)
NZ (2) NZ576693A (de)
PT (1) PT2086525E (de)
TW (2) TWI636795B (de)
WO (1) WO2008063644A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA110604C2 (uk) * 2009-08-26 2016-01-25 Сефалон, Інк. Кристалічна форма поліциклічної сполуки
TWI482621B (zh) 2009-12-23 2015-05-01 Sigma Tau Ind Farmaceuti 青蒿素基藥物與其他化學治療劑的抗癌組合物
TWI573792B (zh) 2012-02-01 2017-03-11 歐陸斯迪公司 新穎治療劑
US9771325B2 (en) 2014-02-14 2017-09-26 Council Of Scientific & Industrial Research Tricyclic compounds and preparation thereof
WO2015121876A1 (en) * 2014-02-14 2015-08-20 Council Of Scientific & Industrial Research Novel tricyclic compounds and preparation thereof
GB201409471D0 (en) 2014-05-28 2014-07-09 Euro Celtique Sa Pharmaceutical composition
GB201409485D0 (en) 2014-05-28 2014-07-09 Euro Celtique Sa Pharmaceutical composition
GB201409488D0 (en) 2014-05-28 2014-07-09 Euro Celtique Sa Pharmaceutical composition
US10150772B2 (en) * 2014-11-26 2018-12-11 Cephalon, Inc. Crystalline forms of PARP inhibitors
CN104961798A (zh) * 2015-06-28 2015-10-07 杨洋 作为parp抑制剂的化合物
WO2018068832A1 (en) 2016-10-11 2018-04-19 Euro-Celtique S.A. Hodgkin lymphoma therapy
GB201709403D0 (en) 2017-06-13 2017-07-26 Euro Celtique Sa Compounds for treating sarcoma
GB201709405D0 (en) 2017-06-13 2017-07-26 Euro Celtique Sa Compounds for treating ovarian cancer
GB201709406D0 (en) 2017-06-13 2017-07-26 Euro-Cletique S A Compounds for treating TNBC
GB201709402D0 (en) 2017-06-13 2017-07-26 Euro Celtique Sa Compounds for treating t-pll
CN113952452A (zh) * 2021-11-16 2022-01-21 苏州伊瑞斯科技有限公司 一种基于碳点的肿瘤放疗增敏剂及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197785B1 (en) * 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6635642B1 (en) * 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
CA2332279A1 (en) * 1998-05-15 1999-11-25 Jia-He Li Carboxamide compounds, compositions, and methods for inhibiting parp activity
US7122679B2 (en) * 2000-05-09 2006-10-17 Cephalon, Inc. Multicyclic compounds and the use thereof
US20060276497A1 (en) * 2000-05-09 2006-12-07 Cephalon, Inc. Novel multicyclic compounds and the use thereof
WO2003015785A1 (en) * 2001-08-15 2003-02-27 Icos Corporation 2h-phthalazin-1-ones and methods for use thereof
KR20090130156A (ko) * 2004-09-22 2009-12-17 화이자 인코포레이티드 폴리(에이디피-리보오스) 폴리머라제 저해제를 포함하는 치료 배합물
US7728026B2 (en) * 2005-04-11 2010-06-01 Abbott Laboratories, Inc. 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors

Also Published As

Publication number Publication date
EP2086525B1 (de) 2010-10-06
CN101784268A (zh) 2010-07-21
AU2007321987B2 (en) 2014-01-23
TWI636795B (zh) 2018-10-01
CA2671517A1 (en) 2008-05-29
AR063869A1 (es) 2009-02-25
IL198519A0 (en) 2010-02-17
CN101784268B (zh) 2013-06-19
CL2007003331A1 (es) 2008-07-04
AU2007321987A1 (en) 2008-05-29
TW201601762A (zh) 2016-01-16
HK1137347A1 (en) 2010-07-30
CA2671517C (en) 2015-01-27
PT2086525E (pt) 2010-12-09
IL198519A (en) 2014-07-31
ES2352817T3 (es) 2011-02-23
MX2009005292A (es) 2009-08-13
JP5542444B2 (ja) 2014-07-09
NZ576693A (en) 2011-12-22
TWI519313B (zh) 2016-02-01
US20080146556A1 (en) 2008-06-19
WO2008063644A1 (en) 2008-05-29
JP2010510312A (ja) 2010-04-02
EP2086525A1 (de) 2009-08-12
NZ595522A (en) 2013-04-26
TW200829276A (en) 2008-07-16
ATE483456T1 (de) 2010-10-15

Similar Documents

Publication Publication Date Title
DE602007009717D1 (de) Verfahren zur strahlensensibilisierung von tumoren mit einem strahlensensibilisierungsmittel
BRPI0912582A2 (pt) Método de tratar câncer utilizando um inibidor cmet e axl e um inibidor erbb
ATE556469T1 (de) Verfahren mit mehrweg-koaxialstecker
DK2171090T3 (da) Genekspressionsmarkører for tumorresistens over for HER2-inhibitorbehandling
BRPI0908351A2 (pt) Método implementado por computador para determinar um volume do horizonte
DE112007001421A5 (de) Mikroreaktoren-Array, Vorrichtung mit einem Mikroreaktoren-Array und Verfahren zur Verwendung eines Mikroreaktoren-Arrays
DE602007012538D1 (de) Verfahren und Vorrichtung zur Durchführung delegierter Transaktionen
DE502007006736D1 (de) Verfahren zur automatischen Modifikation eines Programms
DE112006003449A5 (de) Verfahren zur Beschichtung eines Bauteils
DE602006015892D1 (de) Verfahren zur Beschichtung von metallen
AT505105A3 (de) Verfahren zur beurteilung der fahrbarkeit von fahrzeugen
ATE516362T1 (de) Verfahren zur herstellung von biodiesel
ATE463162T1 (de) Verfahren zur verstärkung der wirksamkeit von ethaboxam
DE502006005540D1 (de) Elektromagnetische strahlung emittierendes optoelektronisches bauelement und verfahren zur herstellung eines optoelektronischen bauelements
ATE480531T1 (de) Verfahren zur herstellung von benzopyran-2- olderivaten
DE502007002941D1 (de) Verfahren zur Datenübertragung
DE602006014011D1 (de) Verfahren zur Verringerung von Lichtinterferenzstreifen
DE602008006314D1 (de) Vorrichtung und Verfahren zur holographischen Datenspeicherung mit einer Phasenmaske
DE602006013177D1 (de) Verfahren zur bearbeitung mit einem offset-werkzeug
ATE482189T1 (de) Verfahren zur hydrocyanierung
DE602006014106D1 (de) Verfahren zur diagnose von prostatakrebs
ATE523483T1 (de) Verfahren zur herstellung von betainen
DE602007003957D1 (de) Verfahren zur verbesserten spiralenschrift vor ort
ATE514666T1 (de) Verfahren zur herstellung von ethen
DE102007044925B8 (de) Verfahren zur Stillstands-/Bewegungsbestimmung von Fahrzeugen